49,337 Shares in Koninklijke Philips (NYSE:PHG) Bought by Carmel Capital Partners LLC

Carmel Capital Partners LLC acquired a new stake in shares of Koninklijke Philips (NYSE:PHG - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 49,337 shares of the technology company's stock, valued at approximately $1,614,000.

Several other hedge funds have also recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Koninklijke Philips by 57.7% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 90,477 shares of the technology company's stock valued at $2,960,000 after purchasing an additional 33,093 shares during the last quarter. Ballentine Partners LLC increased its holdings in Koninklijke Philips by 20.5% during the third quarter. Ballentine Partners LLC now owns 10,492 shares of the technology company's stock valued at $343,000 after buying an additional 1,783 shares during the last quarter. Mount Yale Investment Advisors LLC purchased a new stake in Koninklijke Philips during the third quarter valued at approximately $292,000. International Assets Investment Management LLC purchased a new stake in Koninklijke Philips during the third quarter valued at approximately $1,360,000. Finally, Eastern Bank purchased a new stake in Koninklijke Philips during the third quarter valued at approximately $88,000. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Price Performance

Shares of NYSE PHG traded down $0.94 during midday trading on Friday, reaching $26.61. The stock had a trading volume of 868,370 shares, compared to its average volume of 983,825. The stock has a 50-day moving average of $30.45 and a 200-day moving average of $28.13. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16. The company has a market capitalization of $25.01 billion, a price-to-earnings ratio of -63.36, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. Koninklijke Philips has a 12-month low of $19.49 and a 12-month high of $32.91.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PHG. Jefferies Financial Group raised shares of Koninklijke Philips from an "underperform" rating to a "hold" rating in a report on Tuesday, October 29th. StockNews.com raised shares of Koninklijke Philips from a "hold" rating to a "buy" rating in a report on Monday, July 15th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold".

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.